Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

http://www.wikidata.org/entity/Q42877912

about

Oxidative Stress Signaling in Alzheimers Disease Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes Inflammatory process in Alzheimer's Disease Blood biomarkers for brain injury: What are we measuring?Inflammation and Alzheimer's disease Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors The role of biomarkers in clinical trials for Alzheimer disease Brain injury-associated biomarkers of TGF-beta1, S100B, GFAP, NF-L, tTG, AbetaPP, and tau were concomitantly enhanced and the UPS was impaired during acute brain injury caused by Toxocara canis in mice.Interleukin-1 and the immunogenetics of Alzheimer disease.The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.Aging, Alzheimer's, and APOE genotype influence the expression and neuronal distribution patterns of microtubule motor protein dynactin-P50 Brain structure and cognitive correlates of body mass index in healthy older adults Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.Trisomy 21 and the brain Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease.S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway.Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis.Brain Atrophy, Anti-Smooth Muscle Antibody and Cognitive Impairment: An Association Study.Differential effects of interleukin-1beta and S100B on amyloid precursor protein in rat retinal neurons Impact of body mass index on neuronal fiber bundle lengths among healthy older adults.Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease.S100beta induction of the proinflammatory cytokine interleukin-6 in neurons.Neuroinflammation and copper in Alzheimer's disease.Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice Alzheimer's - Looking beyond plaques.Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.Role of Activated Glia and of Glial Cytokines in Alzheimer's Disease: A Review Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy Human astrocytes in the diseased brain.S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.Immunocytochemical characterization of Alzheimer disease hallmarks in APP/PS1 transgenic mice treated with a new anti-amyloid-β vaccine.Botulinum neurotoxin C initiates two different programs for neurite degeneration and neuronal apoptosis

P2860

Q22241327-930A3125-B49D-4A88-9D2E-DA9EA29FD7D5 Q24633831-9116C8FB-AADB-4F6F-8285-0DFF3DCB771E Q26750987-404B5078-F9A5-491C-9BD5-DFC924022C52 Q26797413-91AD444E-E71A-42C8-A1E5-805942DF4070 Q27500412-3D3F9C6B-7BCB-42B4-A7A3-C20C6A91049B Q28067275-65C8A6B5-95A9-476C-8DA6-3746EDED9F85 Q28138617-307A98C7-0508-4FB4-8C1C-6F1D1BC868B5 Q28216434-57ECEDD6-E64A-4EE2-9FCB-D2FEF882FE9A Q28576453-C61EC07C-AC19-4C37-BDDF-DEB833FECD94 Q31032781-94D91EAC-146F-4D89-8D17-F0E54C2688CA Q33345929-779FA103-C2A5-405E-9E9B-130C84A8A201 Q33941294-D355FF9A-D7C6-4FE8-AD92-67BCE30F2D49 Q34013763-62301FBC-7C28-4885-B5FC-49415F4190F5 Q34245979-0046FD56-5C08-4FA1-B8D5-C604E1787B93 Q35094556-83670721-F4AE-44DA-BC68-7FF16928230C Q35216177-31DE0A08-830C-42D8-8C98-D1A5DBABE39A Q35243251-0C5FB05B-2838-4699-944A-E1F4AFEB41C7 Q35791396-1857A7BF-0670-4B8B-BB44-037583F6CCC8 Q35815212-D09C130A-E11D-45BB-B3ED-3AC70BA46A20 Q35841991-C39C363D-4DD5-4530-B68B-DF3F826A54AF Q35854503-C1B8FF17-BF00-4B1F-AA68-09648E5DE2AA Q36092100-991CD352-3FA1-40DE-89AF-3F8554D10732 Q36411027-8D37612C-CF10-487E-A092-ADDDC5AA819A Q37113208-5470F195-F0AA-430D-B4A8-93DE17AD5E67 Q37131312-F991247F-69EA-4581-9E99-227A452E4CD3 Q37257692-E6ED9296-677F-4707-A14A-C66785DE5111 Q37315943-034D7CE8-1EC0-45E0-AD25-3C402E070624 Q37324120-00A17AAD-EA08-48D1-9833-C9C5C429957F Q37332541-03CA8FCF-8448-402B-B5FD-2663DE34AE28 Q37393152-FB790BE6-D6C2-4002-92D6-40015A4B7866 Q37480839-E4C761FD-813C-406D-B2AF-4576D7F12BAD Q37520323-076D0BD4-B107-4D1A-877F-E56B01EA6E3A Q37967694-A3CFB9D3-B5C6-46B3-B3D2-AF5E4ACA9E67 Q37982377-23407117-A686-41B5-A302-6FB557B4ADBB Q38183363-BC1EC11A-2ABF-4B8D-8B04-17E9460A444F Q38239646-1339617C-2BF2-479F-A252-E14D42D73063 Q39141123-6AC5405B-CA47-4403-AE28-22DB26574B78 Q41863070-ECA7DB76-1DED-47AB-A941-29930CE6BC6D Q42073963-7707937C-AAFF-4E8C-AE46-36970989920F Q42136284-4ACEF296-221E-44E5-BEE8-5CE7593DE042

P2860

Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

http://www.wikidata.org/entity/Q42877912

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Correlation of astrocytic S100 ...... laques of Alzheimer's disease.

@en

Correlation of astrocytic S100 ...... laques of Alzheimer's disease.

@nl

type

label

Correlation of astrocytic S100 ...... laques of Alzheimer's disease.

@en

Correlation of astrocytic S100 ...... laques of Alzheimer's disease.

@nl

prefLabel

Correlation of astrocytic S100 ...... laques of Alzheimer's disease.

@en

Correlation of astrocytic S100 ...... laques of Alzheimer's disease.

@nl

P1433

Q42877912-D8014050-C0AF-4378-8188-CA0E4B4F1504

P1476

Q42877912-CCAC3B92-531D-4BA9-9576-F63F3DFA916D

P2093

Q42877912-9023D23D-3138-4E18-9958-43B3E7E08BC3

Q42877912-CBE8A3FF-C15C-4B35-A572-8ED903D8F076

Q42877912-DEE741C6-0206-4BD1-989D-5B99E45DEB4B

P2860

Q42877912-0281B4C9-2701-413B-8115-252CEB348D51

Q42877912-08A86C96-6BE3-4B41-A039-5EE12EAF1ECA

Q42877912-0A86A0B5-CE8A-4B05-93C9-D2C65EBB5FC8

Q42877912-0D4D7BCC-B9C6-4C4B-8DDC-097B66FABE23

Q42877912-1B6F6644-6D3A-491A-B43C-CEFB6EB7A59B

Q42877912-1F66F9C9-89EC-4090-A1D8-9E3F15F6F3B1

Q42877912-2F831990-5379-4DEA-B310-BE5E58F17538

Q42877912-618F6A0F-D3D6-4E5E-95F8-37D08AD44109

Q42877912-64AB6DAE-8F10-417D-8230-CDB624363C9C

Q42877912-65EB0501-C959-4A7E-9707-0415290A05DE

P304

Q42877912-F376AB8A-AA62-4945-A04A-4A077989617C

P31

Q42877912-5A5DE926-48FB-4681-BFCF-91B124FD1E6A

P356

Q42877912-2B6A59B0-71F8-465F-8EA7-C16E94CBB6F6

P433

Q42877912-7E650797-D8EC-496D-A2CD-0B66272301D9

P478

Q42877912-7B064A8D-25C6-463C-A89F-4277539897FB

P577

Q42877912-159592E1-5279-46B6-BB19-A41123FB0471

P698

Q42877912-FB548632-25E8-40D7-9E73-DE3CBE36CDBD

P921

Q42877912-79C2DEAA-DC14-4BC9-B7F0-1BE5881CB20C

Q42877912-A47D263A-A3F1-4FA3-89BD-6FA613106C62

P932

Q42877912-0BD1F7F6-509F-4296-9EE9-11B8E7523596

P356

00005072-199603000-00002

P1433

Journal of Neuropathology & Experimental Neurology

P1476

Correlation of astrocytic S100 ...... plaques of Alzheimer's disease

@en

P2093

J G Sheng

http://www.w3.org/2001/XMLSchema#string

R E Mrak

http://www.w3.org/2001/XMLSchema#string

W S Griffin

http://www.w3.org/2001/XMLSchema#string

P2860

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy.

Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression.

Glial cytokines in Alzheimer's disease: review and pathogenic implications

Purification and characterization of a neurite extension factor from bovine brain

Regional differentiation of the human fetal ependyma: immunocytochemical markers.

Astrocytes and the plaques of Alzheimer's disease.

Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.

Gliosis in human brain: relationship to size but not other properties of astrocytes.

P304

273-279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00005072-199603000-00002

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

1996-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8786385

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3833601

http://www.w3.org/2001/XMLSchema#string